Tristel Plc (LON:TSTL) insider Elizabeth Dixon sold 10,000 shares of the business’s stock in a transaction that occurred on Wednesday, August 16th. The stock was sold at an average price of GBX 273 ($3.54), for a total value of £27,300 ($35,440.74).

Tristel Plc (LON TSTL) remained flat at GBX 276.00 during mid-day trading on Thursday. 38,488 shares of the company traded hands. The stock’s market cap is GBX 116.07 million. Tristel Plc has a 52-week low of GBX 126.12 and a 52-week high of GBX 280.00. The stock has a 50 day moving average price of GBX 233.09 and a 200 day moving average price of GBX 200.49.

COPYRIGHT VIOLATION NOTICE: This piece of content was originally posted by American Banking News and is the sole property of of American Banking News. If you are reading this piece of content on another website, it was copied illegally and reposted in violation of US and international trademark and copyright legislation. The original version of this piece of content can be read at https://www.americanbankingnews.com/2017/08/17/insider-selling-tristel-plc-tstl-insider-sells-10000-shares-of-stock.html.

Separately, FinnCap restated a “corporate” rating and issued a GBX 165 ($2.14) target price on shares of Tristel Plc in a report on Tuesday, May 30th.

About Tristel Plc

Tristel Plc is a United Kingdom-based manufacturer of infection prevention and contamination control products. The Company’s technology is a chlorine dioxide formulation. The Company operates through three segments: Human Healthcare, Animal Healthcare and Contamination Control. The Human Healthcare segment is engaged in the manufacture, development and sale of infection control and hygiene products, which include products that are used primarily for infection control in hospitals.

Receive News & Ratings for Tristel Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tristel Plc and related companies with MarketBeat.com's FREE daily email newsletter.